[A new etiology of inflammatory livedo: thrombocytosis].
D001167:Arteritis / Q000175:diagnosis; D002066:Busulfan / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004916:Erythromelalgia / Q000175:diagnosis; D005260:Female; D005533:Foot Dermatoses / Q000503:physiopathology*; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009461:Neurologic Manifestations; D010759:Phosphorus Isotopes / Q000627:therapeutic use; D010488:Polyarteritis Nodosa / Q000175:diagnosis; D011928:Raynaud Disease / Q000175:diagnosis; D012867:Skin / Q000473:pathology; D012871:Skin Diseases / Q000209:etiology* / Q000473:pathology; D013922:Thrombocytosis / Q000150:complications* / Q000175:diagnosis / Q000453:epidemiology; D013927:Thrombosis / Q000209:etiology
D010759:Phosphorus Isotopes; D002066:Busulfan; D006918:Hydroxyurea
Une nouvelle étiologie du livedo inflammatoire: l'hyperplaguettose.